Capital expenditure decreased 66.9%
Capital expenditure changed -66.9% from the comparable as-filed period. The change ranks at the 100th percentile of 7 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed -66.9% from the comparable as-filed period. The change ranks at the 100th percentile of 7 prior comparable changes.
Cash & equivalents changed +45.6% from the comparable as-filed period.
Free-cash-flow proxy changed +103.1% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
Gross margin changed +393 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross profit changed +39.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed -802.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed +105.6% from the comparable as-filed period. The change ranks at the 57th percentile of 7 prior comparable changes.
Operating income changed +140.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +2583 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed +25.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Stock-based compensation changed +241.4% from the comparable as-filed period. The change ranks at the 100th percentile of 7 prior comparable changes.
Capex / revenue changed -137 basis points from the comparable as-filed period.
Research & development changed -9.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Debt changed +0.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.